Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cerevel Therapeutics Hldg Inc (CERE)

Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?

Revenue growth during what should be a disastrous patent cliff is encouraging.

CERE : 41.33 (-0.72%)
ABBV : 157.06 (-0.76%)
Is AbbVie Stock a Buy Now?

Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable.

ABBV : 157.06 (-0.76%)
CERE : 41.33 (-0.72%)
Is AbbVie Stock a Buy Now?

The company is grappling with losing Humira's patent protection in 2023.

IMGN : 31.23 (unch)
CERE : 41.33 (-0.72%)
ABBV : 157.06 (-0.76%)
4 Top Dividend Stocks Yielding More Than 4% to Buy Hand-Over-Fist This December

These companies offer above-average income streams that should continue rising.

SRC : 42.31 (-1.56%)
CERE : 41.33 (-0.72%)
O : 52.18 (-0.25%)
BEPC : 32.37 (+2.63%)
BEP : 28.60 (+2.22%)
ABBV : 157.06 (-0.76%)
VZ : 39.74 (+0.79%)
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?

The big drugmaker went on a holiday shopping spree.

AGN.AX : 0.765 (+8.51%)
ABBV : 157.06 (-0.76%)
IMGN : 31.23 (unch)
CERE : 41.33 (-0.72%)
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?

Here's what's attracting lucrative buyout offers from big pharmaceutical companies these days.

ABBV : 157.06 (-0.76%)
CERE : 41.33 (-0.72%)
IMGN : 31.23 (unch)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cerevel Therapeutics Holdings, Inc. - CERE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company") (NASDAQ: CERE)....

CERE : 41.33 (-0.72%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cerevel Therapeutics Holdings, Inc. - CERE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company") (NASDAQ: CERE)....

CERE : 41.33 (-0.72%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cerevel Therapeutics Holdings, Inc. - CERE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company") (NASDAQ: CERE)....

CERE : 41.33 (-0.72%)
Why Shares of Cerevel Therapeutics Are Dropping Wednesday

The company reported second-quarter earnings.

CERE : 41.33 (-0.72%)

Barchart Exclusives

Unusual Options Beckon Dave & Buster’s (PLAY) Bulls But Caution is Warranted
While the fundamental argument for PLAY stock is compelling, prospective speculators must respect what the chart is telling them. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar